T. Rowe Price Associates, Inc. 13D and 13G filings for Tenax Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-09-10 5:19 pm Purchase |
2024-08-31 | 13G | Tenax Therapeutics, Inc. TENX |
T. Rowe Price Associates, Inc. | 3,750,000 19.990% |
3,750,000 (New Position) |
Filing |